Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis PR NewswireNovo Nordisk’s Wegovy Gets US Approval for Liver Disease Bloomberg.comNovo Nordisk’s obesity drug Wegovy cleared to treat MASH statnews.comNovo Nordisk’s Wegovy gets accelerated US approval for liver disease MASH ReutersNovo Nordisk’s Wegovy gets accelerated U.S. approval for liver disease The Globe and Mail
